Professor Andrew Nicholson, consultant histopathologist at Royal Brompton & Harefield NHS Foundation Trust and Honorary Professor of Respiratory Pathology at the National Heart and Lung Institute (NHLI), has been recognised for his lifetime scientific achievements in lung cancer research at the world's largest meeting dedicated to lung cancer and other thoracic malignancies.
He was honoured with the Mary J. Matthews Pathology/Translational Research Award for his work on pathology-translational research of thoracic malignancies at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer, in Barcelona on 7 September 2019.
Speaking about his achievement, Professor Andrew Nicholson said: "I was truly delighted to receive this award, which reflects how the Trust, in particular the staff in our pathology department, has helped advance clinical practice for thoracic cancers through translational research, alongside colleagues at the NHLI.”
Professor Nicholson's research interests are centred on both common and rare lung cancers, mesotheliomas, thymic tumours as well as interstitial lung disease. He is a past chair of the IASLC Pathology Committee and a long-standing member of the IASLC Staging and Prognostic Factors Committee.
Royal Brompton and Harefield Hospitals are world leaders in the diagnosis, management and treatment of lung disease. The Trust is the largest centre for the surgical treatment of lung cancer in the UK.
Research into cardiovascular and respiratory medicine is central to the Trust’s mission and its portfolio of cardiovascular and respiratory research encompasses numerous active studies across the breadth of clinical practice.